Format

Send to

Choose Destination
Eur J Immunol. 2008 Nov;38(11):2961-3. doi: 10.1002/eji.200838851.

Can NK cells be a therapeutic target in human type 1 diabetes?

Author information

1
Diabetes Unit, Department of Internal Medicine, Endocrine and Metabolic Sciences and Biochemistry, University of Siena, Siena, Italy. francesco.dotta@alice.it

Abstract

Type 1 diabetes is caused by the autoimmune destruction of insulin-producing cells with consequent hyperglycemia and serious chronic complications. Both innate and adaptive immune responses participate in disease pathogenesis. Studies in animal models and in man have shown that NK cells are involved both in disease progression and in disease protection, thus suggesting that NK cells can represent a potential therapeutic target in type 1 diabetes, once the contribution of these cells to islet autoimmunity has been fully elucidated.

PMID:
18979518
DOI:
10.1002/eji.200838851
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center